Back to search

National and Kapodistrian University of Athens

Προγνωστικοί παράγοντες για μη-ανταπόκριση και απώλεια της ανταπόκρισης σε ασθενείς με φλεγμονώδη νόσο του εντέρου που λαμβάνουν anti-TNF θεραπεία

Abstract

dc:description

Objectives: A substantial number of Crohn’s disease (CD) or ulcerative colitis (UC) patients lose response to anti-TNFa and therapy needs to be intensified. We aimed to prospectively determine predictors and frequency of anti-TNFa non-response or loss of response and therefore the need for dose escalation and de-escalation in CD and UC patients treated with Infliximab or Adalimumab.Methods: All patients were anti-TNF naïve, while concomitant azathioprine was administered for 6 months. In patients initially responding to anti-TNF and subsequently losing clinical response after the first 14 weeks of therapy, dose escalation was scheduled. During the follow up period and after 1 year of intensified administration, anti-TNF was de-escalated in patients in remission.Results: 189 patients (CD=161, UC=28) were started on infliximab (n=123) or adalimumb (n=66); however 38 (20.01%) did not respond to therapy and were excluded from further analysis. From the remaining 151 patients (CD=132, UC=19, infliximab=95, adalimumab=56), 32 (21.2%) needed a dose escalation for maintenance of remission (CD=31, UC=1), during a median 26 month follow up period. Factors associated with anti-TNF dose escalation were azathioprine discontinuation earlier than 6 months in all patients and smoking in CD patients. Most patients achieved clinical remission (n=26, 81.2%) without other interventions and among them, 17 (65.3%) were successfully de-escalated to the standard maintenance infliximab or adalimumab dose schedule, after 1 year of intensified anti-TNF administration.Conclusion: Azathioprine discontinuation earlier than 6 months in IBD patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation. The same holds true for smoking in patients with CD.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Koukouratos, Theodoros
  • Κουκουράτος, Θεόδωρος

Subjects

dc:subject × 8

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/40547

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Koukouratos, Theodoros; Κουκουράτος, Θεόδωρος. Προγνωστικοί παράγοντες για μη-ανταπόκριση και απώλεια της ανταπόκρισης σε ασθενείς με φλεγμονώδη νόσο του εντέρου που λαμβάνουν anti-TNF θεραπεία. National and Kapodistrian University of Athens, 2017. http://hdl.handle.net/10442/hedi/40547